QUEBEC CITY, Feb. 7 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. today announced that Gilles Gagnon, President and Chief Executive Officer of the Company, will present a corporate update at the Bio CEO & Investor Conference 2006 on Wednesday, February 15, 2006, at 3:00 p.m. ET, in the Jade room of the Waldorf-Astoria Hotel in New York City.
A live webcast of this presentation will be available on AEterna Zentaris' website in the Investors section at www.aeternazentaris.com
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is a growing global biopharmaceutical company engaged in the discovery, development and marketing of therapies for cancer and endocrine disorders.
AEterna Zentaris also owns 48.4% of the equity of Atrium Biotechnologies Inc. and 64.8% of its voting rights. Atrium is a developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutritional industries.
News releases and additional information are available at www.aeternazentaris.com.
AETERNA ZENTARIS INC. (FORMERLY/ANCIENNEMENT - LES LABORATOIRES AETERNACONTACT: Media Relations: Paul Burroughs, (418) 652-8525 ext. 406,paul.burroughs@aeternazentaris.com; Investor Relations: Jenene Thomas,(418) 655-6420, jenene.thomas@aeternazentaris.com; To request a free copyof this organization's annual report, please go to http://www.newswire.caand click on reports@cnw.
